Curcumin attenuates ulcerative colitis via regulation of Sphingosine kinases 1 / NF ‐ κB signaling pathway
BioFactors · 2025-01 · 51 (1)
DOI: 10.1002/biof.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 20.01.2025. Verfasst von Xiuli Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Curcumin, Colitis, Ulcerative, NF-kappa B, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Youth Science and Technology Innovation Talent Cultivation Program of FJTCM, Fujian Province Higher Education Industry-University-Research Joint Innovation Project, Education and Research Project for Young and Middle-aged Teachers of Fujian Education Department.
Abstract (Originalsprache)
Curcumin, a compound from Curcuma longa L., has significant anti‐inflammatory properties. However, the mechanisms underlying its anti‐inflammatory activity in dextran sodium sulfate (DSS)‐induced ulcerative colitis (UC) remain inadequately understood. This study aimed to further elucidate the molecular mechanisms of curcumin DSS‐induced UC mice. Our data showed that curcumin alleviated DSS‐induced colitis by reducing intestinal damage and inflammation, increasing goblet cells in colon tissues. Enzyme‐linked immunosorbent assay revealed that curcumin reduced the expression of inflammatory cytokines (tumor necrosis factor‐alpha, interleukin‐1β, and interleukin‐8) in serum and myeloperoxidase in colon tissues. A comprehensive analysis integrating network pharmacology and RNA sequencing (RNA‐seq) revealed significant enrichment of the nuclear factor kappa B (NF‐κB) signaling pathways. Notably, RNA‐seq analysis demonstrated that curcumin significantly downregulated the mRNA expression of sphingosine kinase 1 (SphK1). Furthermore, molecular docking analysis showed that curcumin can bind to SphK1 and NF‐κB. Additionally, curcumin was found to inhibit the activation of the SphK1/NF‐κB signaling pathway in DSS‐induced UC colon tissue. This study addresses pharmacologic and mechanistic perspectives of curcumin that ameliorates DSS‐induced UC and inflammatory response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
- Basic Medical Experimental Teaching Center, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
- Department of Gastroenterology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
ORCID-Profile: Xiuli Zhang, Yao Lin
Förderung
- Youth Science and Technology Innovation Talent Cultivation Program of FJTCM
- Fujian Province Higher Education Industry-University-Research Joint Innovation Project
- Education and Research Project for Young and Middle-aged Teachers of Fujian Education Department
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Zhang, H., Wang, J., Chen, Y., Lin, J., Wang, Q., Wu, C., Chen, H., & Lin, Y. (2025). Curcumin attenuates ulcerative colitis via regulation of Sphingosine kinases 1 / NF ‐ κB signaling pathway. BioFactors, 51(1). https://doi.org/10.1002/biof.70001
Vancouver
Zhang X, Zhang H, Wang J, Chen Y, Lin J, Wang Q, et al. Curcumin attenuates ulcerative colitis via regulation of Sphingosine kinases 1 / NF ‐ κB signaling pathway. BioFactors. 2025;51(1). doi:10.1002/biof.70001
BibTeX
@article{Zhang2025,
author = {Zhang, Xiuli and Zhang, Hao and Wang, Jingting and Chen, Yangyi and Lin, Jiumao and Wang, Qingshui and Wu, Cheng and Chen, Hui and Lin, Yao},
title = {Curcumin attenuates ulcerative colitis via regulation of Sphingosine kinases 1 / NF ‐ κB signaling pathway},
journal = {BioFactors},
year = {2025},
volume = {51},
number = {1},
doi = {10.1002/biof.70001}
}
EUVIMED